{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:31:24Z","timestamp":1773286284707,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T00:00:00Z","timestamp":1384473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"DOI":"10.1038\/emm.2013.124","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T12:31:22Z","timestamp":1384518682000},"page":"e59-e59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Implications and limitations of cellular reprogramming for psychiatric drug development"],"prefix":"10.1038","volume":"45","author":[{"given":"Brian T D","family":"Tobe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G","family":"Brandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S","family":"Nye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan Y","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,15]]},"reference":[{"key":"BFemm2013124_CR1","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1038\/sj.npp.1301639","volume":"33","author":"WT Carpenter","year":"2008","unstructured":"Carpenter WT, Koenig JI . The evolution of drug development in schizophrenia: past issues and future opportunities. Neuropsychopharmacology 2008; 33: 2061\u20132079.","journal-title":"Neuropsychopharmacology"},{"key":"BFemm2013124_CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/11587810-000000000-00000","volume":"25","author":"TR Barnes","year":"2011","unstructured":"Barnes TR, Paton C . Antipsychotic polypharmacy in schizophrenia: benefits and risks. CNS Drugs 2011; 25: 383\u2013399.","journal-title":"CNS Drugs"},{"key":"BFemm2013124_CR3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/YCO.0b013e3283366427","volume":"23","author":"M Zink","year":"2010","unstructured":"Zink M, Englisch S, Meyer-Lindenberg A . Polypharmacy in schizophrenia. Curr Opin Psychiatry 2010; 23: 103\u2013111.","journal-title":"Curr Opin Psychiatry"},{"key":"BFemm2013124_CR4","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163: 1905\u20131917.","journal-title":"Am J Psychiatry"},{"key":"BFemm2013124_CR5","doi-asserted-by":"crossref","first-page":"61rv6","DOI":"10.1126\/scitranslmed.3000446","volume":"2","author":"RE Becker","year":"2010","unstructured":"Becker RE, Greig NH . Lost in translation: neuropsychiatric drug development. Sci Transl Med 2010; 2: 61rv6.","journal-title":"Sci Transl Med"},{"key":"BFemm2013124_CR6","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1371\/journal.pmed.0020392","volume":"2","author":"JR Lacasse","year":"2005","unstructured":"Lacasse JR, Leo J . Serotonin and depression: a disconnect between the advertisements and the scientific literature. PLoS Med 2005; 2: e392.","journal-title":"PLoS Med"},{"key":"BFemm2013124_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1150516","volume":"320","author":"JF Maya Vetencourt","year":"2008","unstructured":"Maya Vetencourt JF, Sale A, Viegi A, Baroncelli L, De Pasquale R, O'Leary OF et al. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 2008; 320: 385\u2013388.","journal-title":"Science"},{"key":"BFemm2013124_CR8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tips.2008.05.004","volume":"29","author":"PJ Cowen","year":"2008","unstructured":"Cowen PJ . Serotonin and depression: pathophysiological mechanism or marketing myth? Trends Pharmacol Sci 2008; 29: 433\u2013436.","journal-title":"Trends Pharmacol Sci"},{"key":"BFemm2013124_CR9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2006.08.009","volume":"7","author":"E Castren","year":"2007","unstructured":"Castren E, Voikar V, Rantamaki T . Role of neurotrophic factors in depression. Curr Opin Pharmacol 2007; 7: 18\u201321.","journal-title":"Curr Opin Pharmacol"},{"key":"BFemm2013124_CR10","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1073\/pnas.0601992103","volume":"103","author":"JM Encinas","year":"2006","unstructured":"Encinas JM, Vaahtokari A, Enikolopov G . Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci USA 2006; 103: 8233\u20138238.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2013124_CR11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1527-3458.2008.00040.x","volume":"14","author":"JP Mostert","year":"2008","unstructured":"Mostert JP, Koch MW, Heerings M, Heersema DJ, De Keyser J . Therapeutic potential of fluoxetine in neurological disorders. CNS Neurosci Ther 2008; 14: 153\u2013164.","journal-title":"CNS Neurosci Ther"},{"key":"BFemm2013124_CR12","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.bcp.2008.02.013","volume":"75","author":"A Krishnan","year":"2008","unstructured":"Krishnan A, Hariharan R, Nair SA, Pillai MR . Fluoxetine mediates G0\/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1. Biochem Pharmacol 2008; 75: 1924\u20131934.","journal-title":"Biochem Pharmacol"},{"key":"BFemm2013124_CR13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/mi.8.5.8","volume":"8","author":"JM Beaulieu","year":"2008","unstructured":"Beaulieu JM, Caron MG . Looking at lithium: molecular moods and complex behaviour. Mol Interv 2008; 8: 230\u2013241.","journal-title":"Mol Interv"},{"key":"BFemm2013124_CR14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1471-4159.2003.02015.x","volume":"87","author":"R Pardo","year":"2003","unstructured":"Pardo R, Andreolotti AG, Ramos B, Picatoste F, Claro E . Opposed effects of lithium on the MEK-ERK pathway in neural cells: inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms. J Neurochem 2003; 87: 417\u2013426.","journal-title":"J Neurochem"},{"key":"BFemm2013124_CR15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.drudis.2008.02.007","volume":"13","author":"LA Catapano","year":"2008","unstructured":"Catapano LA, Manji HK . Kinases as drug targets in the treatment of bipolar disorder. Drug Discov Today 2008; 13: 295\u2013302.","journal-title":"Drug Discov Today"},{"key":"BFemm2013124_CR16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1017\/S1461145706007140","volume":"10","author":"D Tardito","year":"2007","unstructured":"Tardito D, Tiraboschi E, Kasahara J, Racagni G, Popoli M . Reduced CREB phosphorylation after chronic lithium treatment is associated with down-regulation of CaM kinase IV in rat hippocampus. Int J Neuropsychopharmacol 2007; 10: 491\u2013496.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFemm2013124_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1034\/j.1399-5618.1999.010204.x","volume":"1","author":"CG Hahn","year":"1999","unstructured":"Hahn CG, Friedman E . Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord 1999; 1: 81\u201386.","journal-title":"Bipolar Disord"},{"key":"BFemm2013124_CR18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000314310","volume":"62","author":"JA Quiroz","year":"2010","unstructured":"Quiroz JA, Machado-Vieira R, Zarate CA Jr, Manji HK . Novel insights into lithium\u2019s mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 2010; 62: 50\u201360.","journal-title":"Neuropsychobiology"},{"key":"BFemm2013124_CR19","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2217\/pgs.10.127","volume":"11","author":"MJ McCarthy","year":"2010","unstructured":"McCarthy MJ, Leckband SG, Kelsoe JR . Pharmacogenetics of lithium response in bipolar disorder. Pharmacogenomics 2010; 11: 1439\u20131465.","journal-title":"Pharmacogenomics"},{"key":"BFemm2013124_CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/138920009788898028","volume":"10","author":"A Camins","year":"2009","unstructured":"Camins A, Crespo-Biel N, Junyent F, Verdaguer E, Canudas AM, Pallas M . Calpains as a target for therapy of neurodegenerative diseases: putative role of lithium. Curr Drug Metab 2009; 10: 433\u2013447.","journal-title":"Curr Drug Metab"},{"key":"BFemm2013124_CR21","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1176\/appi.ajp.2009.08111633","volume":"166","author":"RH Perlis","year":"2009","unstructured":"Perlis RH, Smoller JW, Ferreira MA, McQuillin A, Bass N, Lawrence J et al. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry 2009; 166: 718\u2013725.","journal-title":"Am J Psychiatry"},{"key":"BFemm2013124_CR22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2265.2008.03182.x","volume":"69","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Ferrari SM, Fallahi P, Berti P, Materazzi G, Barani L et al. Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests. Clin Endocrinol (Oxf) 2008; 69: 148\u2013152.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFemm2013124_CR23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1227\/NEU.0b013e3182262c5b","volume":"70","author":"EU Bagriacik","year":"2011","unstructured":"Bagriacik EU, Baykaner MK, Yaman M, Sivrikaya G, Durdag E, Emmez H et al. Establishment of a primary pleomorphic xanthoastrocytoma cell line: in vitro responsiveness to some chemotherapeutics. Neurosurgery 2011; 70: 188\u2013197.","journal-title":"Neurosurgery"},{"key":"BFemm2013124_CR24","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.4161\/cc.10.12.15883","volume":"10","author":"D Basu","year":"2011","unstructured":"Basu D, Montone KT, Wang LP, Gimotty PA, Hammond R, Diehl JA et al. Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas. Cell Cycle 2011; 10: 2008\u20132016.","journal-title":"Cell Cycle"},{"key":"BFemm2013124_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13577-010-0004-x","volume":"24","author":"M Suzuki","year":"2011","unstructured":"Suzuki M, Ishikawa H, Tanaka A, Mataga I . Heterogeneity of anticancer drug sensitivity in squamous cell carcinoma of the tongue. Hum Cell 2011; 24: 21\u201329.","journal-title":"Hum Cell"},{"key":"BFemm2013124_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcancer.2003.11.003","volume":"14","author":"R Liu","year":"2004","unstructured":"Liu R, Hsieh CY, Lam KS . New approaches in identifying drugs to inactivate oncogene products. Semin Cancer Biol 2004; 14: 13\u201321.","journal-title":"Semin Cancer Biol"},{"key":"BFemm2013124_CR27","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145\u20131147.","journal-title":"Science"},{"key":"BFemm2013124_CR28","doi-asserted-by":"crossref","first-page":"11227","DOI":"10.1074\/jbc.M109.086389","volume":"285","author":"J Cai","year":"2010","unstructured":"Cai J, Li W, Su H, Qin D, Yang J, Zhu F et al. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem 2010; 285: 11227\u201311234.","journal-title":"J Biol Chem"},{"key":"BFemm2013124_CR29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MOH.0b013e32833a25ee","volume":"17","author":"S Kaneko","year":"2010","unstructured":"Kaneko S, Otsu M, Nakauchi H . Reprogramming adult hematopoietic cells. Curr Opin Hematol 2010; 17: 271\u2013275.","journal-title":"Curr Opin Hematol"},{"key":"BFemm2013124_CR30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nature08436","volume":"461","author":"JB Kim","year":"2009","unstructured":"Kim JB, Greber B, Arauzo-Bravo MJ, Meyer J, Park KI, Zaehres H et al. Direct reprogramming of human neural stem cells by OCT4. Nature 2009; 461: 649\u20133.","journal-title":"Nature"},{"key":"BFemm2013124_CR31","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1098\/rstb.2011.0017","volume":"366","author":"JJ Unternaehrer","year":"2011","unstructured":"Unternaehrer JJ, Daley GQ . Induced pluripotent stem cells for modelling human diseases. Philos Trans R Soc Lond Ser B 2011; 366: 2274\u20132285.","journal-title":"Philos Trans R Soc Lond Ser B"},{"key":"BFemm2013124_CR32","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/nprot.2007.418","volume":"2","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Okita K, Nakagawa M, Yamanaka S . Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007; 2: 3081\u20133089.","journal-title":"Nat Protoc"},{"key":"BFemm2013124_CR33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/mp.2011.13","volume":"16","author":"CH Chiang","year":"2011","unstructured":"Chiang CH, Su Y, Wen Z, Yoritomo N, Ross CA, Margolis RL et al. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry 2011; 16: 358\u2013360.","journal-title":"Mol Psychiatry"},{"key":"BFemm2013124_CR34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09915","volume":"473","author":"KJ Brennand","year":"2011","unstructured":"Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011; 473: 221\u2013225.","journal-title":"Nature"},{"key":"BFemm2013124_CR35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1517\/14712598.2011.558837","volume":"11","author":"KS Sidhu","year":"2011","unstructured":"Sidhu KS . New approaches for the generation of induced pluripotent stem cells. Expert Opin Biol Ther 2011; 11: 569\u2013579.","journal-title":"Expert Opin Biol Ther"},{"key":"BFemm2013124_CR36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nmeth.1580","volume":"8","author":"FJ Muller","year":"2011","unstructured":"Muller FJ, Schuldt BM, Williams R, Mason D, Altun G, Papapetrou EP et al. A bioinformatic assay for pluripotency in human cells. Nat Methods 2011; 8: 315\u2013317.","journal-title":"Nat Methods"},{"key":"BFemm2013124_CR37","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1073\/pnas.1103388108","volume":"108","author":"SE Howden","year":"2011","unstructured":"Howden SE, Gore A, Li Z, Fung HL, Nisler BS, Nie J et al. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc Natl Acad Sci USA 2011; 108: 6537\u20136542.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2013124_CR38","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/mp.2013.67","volume":"18","author":"O Robicsek","year":"2013","unstructured":"Robicsek O, Karry R, Petit I, Salman-Kesner N, Muller FJ, Klein E et al. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry 2013; 18: 1067\u20131076.","journal-title":"Mol Psychiatry"},{"key":"BFemm2013124_CR39","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1093\/hmg\/ddn065","volume":"17","author":"GW Yeo","year":"2008","unstructured":"Yeo GW, Coufal N, Aigner S, Winner B, Scolnick JA, Marchetto MC et al. Multiple layers of molecular controls modulate self-renewal and neuronal lineage specification of embryonic stem cells. Hum Mol Genet 2008; 17: R67\u2013R75.","journal-title":"Hum Mol Genet"},{"key":"BFemm2013124_CR40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jcb.21891","volume":"105","author":"SK Dhara","year":"2008","unstructured":"Dhara SK, Stice SL . Neural differentiation of human embryonic stem cells. J Cell Biochem 2008; 105: 633\u2013640.","journal-title":"J Cell Biochem"},{"key":"BFemm2013124_CR41","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1073\/pnas.1014041108","volume":"108","author":"W Li","year":"2011","unstructured":"Li W, Sun W, Zhang Y, Wei W, Ambasudhan R, Xia P et al. Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors. Proc Natl Acad Sci USA 2011; 108: 8299\u20138304.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2013124_CR42","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nprot.2010.35","volume":"5","author":"G Lee","year":"2010","unstructured":"Lee G, Chambers SM, Tomishima MJ, Studer L . Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc 2010; 5: 688\u2013701.","journal-title":"Nat Protoc"},{"key":"BFemm2013124_CR43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L . Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009; 27: 275\u2013280.","journal-title":"Nat Biotechnol"},{"key":"BFemm2013124_CR44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.stem.2011.01.013","volume":"8","author":"HN Nguyen","year":"2011","unstructured":"Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, Gujar P et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 2011; 8: 267\u2013280.","journal-title":"Cell Stem Cell"},{"key":"BFemm2013124_CR45","doi-asserted-by":"crossref","first-page":"15921","DOI":"10.1073\/pnas.1010209107","volume":"107","author":"G Hargus","year":"2010","unstructured":"Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA 2010; 107: 15921\u201315926.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2013124_CR46","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1089\/scd.2010.0560","volume":"21","author":"L Emdad","year":"2012","unstructured":"Emdad L, D'Souza SL, Kothari HP, Qadeer ZA, Germano IM . Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. Stem Cells Dev 2012; 21: 404\u2013410.","journal-title":"Stem Cells Dev"},{"key":"BFemm2013124_CR47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature09805","volume":"471","author":"A Gore","year":"2011","unstructured":"Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011; 471: 63\u201367.","journal-title":"Nature"},{"key":"BFemm2013124_CR48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature09871","volume":"471","author":"SM Hussein","year":"2011","unstructured":"Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011; 471: 58\u201362.","journal-title":"Nature"},{"key":"BFemm2013124_CR49","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.stem.2010.07.017","volume":"7","author":"Y Mayshar","year":"2010","unstructured":"Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7: 521\u2013531.","journal-title":"Cell Stem Cell"},{"key":"BFemm2013124_CR50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.1783","volume":"29","author":"GL Boulting","year":"2011","unstructured":"Boulting GL, Kiskinis E, Croft GF, Amoroso MW, Oakley DH, Wainger BJ et al. A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 2011; 29: 279\u2013286.","journal-title":"Nat Biotechnol"},{"key":"BFemm2013124_CR51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev-med-100708-204735","volume":"61","author":"P Stankiewicz","year":"2010","unstructured":"Stankiewicz P, Lupski JR . Structural variation in the human genome and its role in disease. Annu Rev Med 2010; 61: 437\u2013455.","journal-title":"Annu Rev Med"},{"key":"BFemm2013124_CR52","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1073\/pnas.0910012107","volume":"107","author":"BY Hu","year":"2010","unstructured":"Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010; 107: 4335\u20134340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2013124_CR53","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1073\/pnas.1007753108","volume":"108","author":"JE Kim","year":"2011","unstructured":"Kim JE, O\u2019Sullivan ML, Sanchez CA, Hwang M, Israel MA, Brennand K et al. Investigating synapse formation and function using human pluripotent stem cell-derived neurons. Proc Natl Acad Sci USA 2011; 108: 3005\u20133010.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2013124_CR54","doi-asserted-by":"crossref","first-page":"17668","DOI":"10.1073\/pnas.1004487107","volume":"107","author":"SJ Chamberlain","year":"2010","unstructured":"Chamberlain SJ, Chen PF, Ng KY, Bourgois-Rocha F, Lemtiri-Chlieh F, Levine ES et al. Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader\u2013Willi syndromes. Proc Natl Acad Sci USA 2010; 107: 17668\u201317673.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2013124_CR55","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature10284","volume":"476","author":"M Caiazzo","year":"2011","unstructured":"Caiazzo M, Dell'anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 2011; 476: 224\u2013227.","journal-title":"Nature"},{"key":"BFemm2013124_CR56","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08797","volume":"463","author":"T Vierbuchen","year":"2010","unstructured":"Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M . Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010; 463: 1035\u20131041.","journal-title":"Nature"},{"key":"BFemm2013124_CR57","doi-asserted-by":"crossref","first-page":"7838","DOI":"10.1073\/pnas.1103113108","volume":"108","author":"J Kim","year":"2011","unstructured":"Kim J, Efe JA, Zhu S, Talantova M, Yuan X, Wang S et al. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci USA 2011; 108: 7838\u20137843.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2013124_CR58","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1073\/pnas.1019743108","volume":"108","author":"KS Kim","year":"2011","unstructured":"Kim KS, Lee HJ, Jeong HS, Li J, Teng YD, Sidman RL et al. Self-renewal induced efficiently, safely, and effective therapeutically with one regulatable gene in a human somatic progenitor cell. Proc Natl Acad Sci USA 2011; 108: 4876\u20134881.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2013124_CR59","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature10135","volume":"474","author":"T Zhao","year":"2011","unstructured":"Zhao T, Zhang ZN, Rong Z, Xu Y . Immunogenicity of induced pluripotent stem cells. Nature 2011; 474: 212\u2013215.","journal-title":"Nature"},{"key":"BFemm2013124_CR60","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","volume":"13","author":"EJ Nestler","year":"2010","unstructured":"Nestler EJ, Hyman SE . Animal models of neuropsychiatric disorders. Nat Neurosci 2010; 13: 1161\u20131169.","journal-title":"Nat Neurosci"},{"key":"BFemm2013124_CR61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","volume":"143","author":"MC Marchetto","year":"2010","unstructured":"Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, Mu Y et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010; 143: 527\u2013539.","journal-title":"Cell"},{"key":"BFemm2013124_CR62","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nn.2741","volume":"14","author":"P Penzes","year":"2011","unstructured":"Penzes P, Cahill ME, Jones KA, VanLeeuwen JE, Woolfrey KM . Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 2011; 14: 285\u2013293.","journal-title":"Nat Neurosci"},{"key":"BFemm2013124_CR63","doi-asserted-by":"crossref","first-page":"pe66","DOI":"10.1126\/scisignal.293pe66","volume":"2","author":"PV Ryder","year":"2009","unstructured":"Ryder PV, Faundez V . Schizophrenia: the \u2018BLOC\u2019 may be in the endosomes. Sci Signal 2009; 2: pe66.","journal-title":"Sci Signal"},{"key":"BFemm2013124_CR64","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.psyneuen.2004.09.004","volume":"30","author":"U Henning","year":"2005","unstructured":"Henning U, Krieger K, Loeffler S, Rivas F, Orozco G, de Castro MG et al. Increased levels of glucocorticoid receptors and enhanced glucocorticoid receptor auto-regulation after hydrocortisone challenge in B-lymphoblastoids from patients with affective disorders. Psychoneuroendocrinology 2005; 30: 325\u2013332.","journal-title":"Psychoneuroendocrinology"},{"key":"BFemm2013124_CR65","doi-asserted-by":"crossref","first-page":"e49700","DOI":"10.1371\/journal.pone.0049700","volume":"7","author":"L D'Aiuto","year":"2012","unstructured":"D'Aiuto L, Di Maio R, Heath B, Raimondi G, Milosevic J, Watson AM et al. Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells. PLoS One 2012; 7: e49700.","journal-title":"PLoS One"},{"key":"BFemm2013124_CR66","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.npp.1300911","volume":"31","author":"A Basta-Kaim","year":"2006","unstructured":"Basta-Kaim A, Budziszewska B, Jaworska-Feil L, Tetich M, Kubera M, Leskiewicz M et al. Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells-an involvement of protein kinases. Neuropsychopharmacology 2006; 31: 853\u2013865.","journal-title":"Neuropsychopharmacology"},{"key":"BFemm2013124_CR67","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00702-007-0747-z","volume":"114","author":"S Kurosawa","year":"2007","unstructured":"Kurosawa S, Hashimoto E, Ukai W, Toki S, Saito S, Saito T . Olanzapine potentiates neuronal survival and neural stem cell differentiation: regulation of endoplasmic reticulum stress response proteins. J Neural Transm 2007; 114: 1121\u20131128.","journal-title":"J Neural Transm"},{"key":"BFemm2013124_CR68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0306-4522(02)00577-8","volume":"117","author":"R Hashimoto","year":"2003","unstructured":"Hashimoto R, Senatorov V, Kanai H, Leeds P, Chuang DM . Lithium stimulates progenitor proliferation in cultured brain neurons. Neuroscience 2003; 117: 55\u201361.","journal-title":"Neuroscience"},{"key":"BFemm2013124_CR69","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1471-4159.2004.02725.x","volume":"91","author":"P Laeng","year":"2004","unstructured":"Laeng P, Pitts RL, Lemire AL, Drabik CE, Weiner A, Tang H et al. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 2004; 91: 238\u2013251.","journal-title":"J Neurochem"},{"key":"BFemm2013124_CR70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2007.12.019","volume":"1196","author":"K Hisaoka","year":"2008","unstructured":"Hisaoka K, Maeda N, Tsuchioka M, Takebayashi M . Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells: a possible contribution to GDNF production. Brain Res 2008; 1196: 53\u201358.","journal-title":"Brain Res"},{"key":"BFemm2013124_CR71","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.biopsych.2007.12.017","volume":"64","author":"X Zhou","year":"2008","unstructured":"Zhou X, Barrett TB, Kelsoe JR . Promoter variant in the GRK3 gene associated with bipolar disorder alters gene expression. Biol Psychiatry 2008; 64: 104\u2013110.","journal-title":"Biol Psychiatry"},{"key":"BFemm2013124_CR72","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.biopsych.2008.11.024","volume":"65","author":"W Huang","year":"2009","unstructured":"Huang W, Li MD . Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol Psychiatry 2009; 65: 702\u2013705.","journal-title":"Biol Psychiatry"},{"key":"BFemm2013124_CR73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/mp.2008.10","volume":"14","author":"S Yang","year":"2009","unstructured":"Yang S, Van Dongen HP, Wang K, Berrettini W, Bucan M . Assessment of circadian function in fibroblasts of patients with bipolar disorder. Mol Psychiatry 2009; 14: 143\u2013155.","journal-title":"Mol Psychiatry"},{"key":"BFemm2013124_CR74","doi-asserted-by":"crossref","unstructured":"McCarthy MJ, Wei H, Marnoy Z, Darvish R, McPhie D, Cohen B et al. Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients. Translational Psychiatry 2013 (in press).","DOI":"10.1038\/tp.2013.90"},{"key":"BFemm2013124_CR75","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neulet.2008.08.091","volume":"446","author":"A Yoshikawa","year":"2008","unstructured":"Yoshikawa A, Shimada H, Numazawa K, Sasaki T, Ikeda M, Kawashima M et al. Establishment of human cell lines showing circadian rhythms of bioluminescence. Neurosci Lett 2008; 446: 40\u201344.","journal-title":"Neurosci Lett"},{"key":"BFemm2013124_CR76","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/0748730410385281","volume":"25","author":"E Kowalska","year":"2010","unstructured":"Kowalska E, Moriggi E, Bauer C, Dibner C, Brown SA . The circadian clock starts ticking at a developmentally early stage. J Biol Rhythms 2010; 25: 442\u2013449.","journal-title":"J Biol Rhythms"},{"key":"BFemm2013124_CR77","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1087057110372257","volume":"15","author":"A Kiselyuk","year":"2010","unstructured":"Kiselyuk A, Farber-Katz S, Cohen T, Lee SH, Geron I, Azimi B et al. Phenothiazine neuroleptics signal to the human insulin promoter as revealed by a novel high-throughput screen. J Biomol Screen 2010; 15: 663\u2013670.","journal-title":"J Biomol Screen"},{"key":"BFemm2013124_CR78","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.scr.2011.01.002","volume":"6","author":"E Kiris","year":"2011","unstructured":"Kiris E, Nuss JE, Burnett JC, Kota KP, Koh DC, Wanner LM et al. Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery. Stem Cell Res 2011; 6: 195\u2013205.","journal-title":"Stem Cell Res"},{"key":"BFemm2013124_CR79","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1128\/JVI.73.8.6841-6851.1999","volume":"73","author":"WP Lynch","year":"1999","unstructured":"Lynch WP, Sharpe AH, Snyder EY . Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration. J Virol 1999; 73: 6841\u20136851.","journal-title":"J Virol"},{"key":"BFemm2013124_CR80","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.1128\/jvi.70.12.8896-8907.1996","volume":"70","author":"WP Lynch","year":"1996","unstructured":"Lynch WP, Snyder EY, Qualtiere L, Portis JL, Sharpe AH . Late virus replication events in microglia are required for neurovirulent retrovirus-induced spongiform neurodegeneration: evidence from neural progenitor-derived chimeric mouse brains. J Virol 1996; 70: 8896\u20138907.","journal-title":"J Virol"},{"key":"BFemm2013124_CR81","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coph.2011.05.007","volume":"11","author":"BT Tobe","year":"2011","unstructured":"Tobe BT, Snyder EY, Nye JS . Modeling complex neuropsychiatric disorders with human induced pluripotent stem cells. Curr Opin Pharmacol 2011; 11: 521\u2013527.","journal-title":"Curr Opin Pharmacol"},{"key":"BFemm2013124_CR82","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","volume":"457","author":"AD Ebert","year":"2009","unstructured":"Ebert AD, Yu J, Rose FF Jr., Mattis VB, Lorson CL, Thomson JA et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277\u2013280.","journal-title":"Nature"},{"key":"BFemm2013124_CR83","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nbt.1502","volume":"26","author":"D Huangfu","year":"2008","unstructured":"Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008; 26: 1269\u20131275.","journal-title":"Nat Biotechnol"},{"key":"BFemm2013124_CR84","doi-asserted-by":"crossref","first-page":"8912","DOI":"10.1073\/pnas.0903860106","volume":"106","author":"CA Lyssiotis","year":"2009","unstructured":"Lyssiotis CA, Foreman RK, Staerk J, Garcia M, Mathur D, Markoulaki S et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci USA 2009; 106: 8912\u20138917.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2013124_CR85","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/cr.2011.108","volume":"21","author":"Q Wang","year":"2011","unstructured":"Wang Q, Xu X, Li J, Liu J, Gu H, Zhang R et al. Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells. Cell Res 2011; 21: 1424\u20131435.","journal-title":"Cell Res"},{"key":"BFemm2013124_CR86","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nbt.1530","volume":"27","author":"J Deng","year":"2009","unstructured":"Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, Antosiewicz-Bourget J et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 2009; 27: 353\u2013360.","journal-title":"Nat Biotechnol"},{"key":"BFemm2013124_CR87","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.stem.2007.05.014","volume":"1","author":"N Maherali","year":"2007","unstructured":"Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007; 1: 55\u201370.","journal-title":"Cell Stem Cell"},{"key":"BFemm2013124_CR88","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature08180","volume":"460","author":"S Yamanaka","year":"2009","unstructured":"Yamanaka S . Elite and stochastic models for induced pluripotent stem cell generation. Nature 2009; 460: 49\u201352.","journal-title":"Nature"},{"key":"BFemm2013124_CR89","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrg2955","volume":"12","author":"K Plath","year":"2011","unstructured":"Plath K, Lowry WE . Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet 2011; 12: 253\u2013265.","journal-title":"Nat Rev Genet"},{"key":"BFemm2013124_CR90","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.semcdb.2009.01.005","volume":"20","author":"W Renthal","year":"2009","unstructured":"Renthal W, Nestler EJ . Histone acetylation in drug addiction. Semin Cell Dev Biol 2009; 20: 387\u2013394.","journal-title":"Semin Cell Dev Biol"},{"key":"BFemm2013124_CR91","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1523\/JNEUROSCI.1758-09.2009","volume":"29","author":"HE Covington III","year":"2009","unstructured":"Covington HE III, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O et al. Antidepressant actions of histone deacetylase inhibitors. J Neurosci 2009; 29: 11451\u201311460.","journal-title":"J Neurosci"},{"key":"BFemm2013124_CR92","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biopsych.2010.03.029","volume":"69","author":"R Pidsley","year":"2011","unstructured":"Pidsley R, Mill J . Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research. Biol Psychiatry 2011; 69: 146\u2013156.","journal-title":"Biol Psychiatry"},{"key":"BFemm2013124_CR93","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.chembiol.2006.05.004","volume":"13","author":"MG Lee","year":"2006","unstructured":"Lee MG, Wynder C, Schmidt DM, McCafferty DG, Shiekhattar R . Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol 2006; 13: 563\u2013567.","journal-title":"Chem Biol"},{"key":"BFemm2013124_CR94","doi-asserted-by":"crossref","first-page":"8058","DOI":"10.1021\/bi700664y","volume":"46","author":"M Yang","year":"2007","unstructured":"Yang M, Culhane JC, Szewczuk LM, Jalili P, Ball HL, Machius M et al. Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. Biochemistry 2007; 46: 8058\u20138065.","journal-title":"Biochemistry"},{"key":"BFemm2013124_CR95","doi-asserted-by":"crossref","first-page":"17775","DOI":"10.1074\/jbc.M109.003087","volume":"284","author":"A Karytinos","year":"2009","unstructured":"Karytinos A, Forneris F, Profumo A, Ciossani G, Battaglioli E, Binda C et al. A novel mammalian flavin-dependent histone demethylase. J Biol Chem 2009; 284: 17775\u201317782.","journal-title":"J Biol Chem"},{"key":"BFemm2013124_CR96","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1002\/stem.240","volume":"27","author":"W Li","year":"2009","unstructured":"Li W, Zhou H, Abujarour R, Zhu S, Young Joo J, Lin T et al. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 2009; 27: 2992\u20133000.","journal-title":"Stem Cells"},{"key":"BFemm2013124_CR97","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/npp.2009.188","volume":"35","author":"T Perisic","year":"2010","unstructured":"Perisic T, Zimmermann N, Kirmeier T, Asmus M, Tuorto F, Uhr M et al. Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology 2010; 35: 792\u2013805.","journal-title":"Neuropsychopharmacology"},{"key":"BFemm2013124_CR98","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neuropharm.2008.09.019","volume":"56","author":"IT Yu","year":"2009","unstructured":"Yu IT, Park JY, Kim SH, Lee JS, Kim YS, Son H . Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology 2009; 56: 473\u2013480.","journal-title":"Neuropharmacology"},{"key":"BFemm2013124_CR99","doi-asserted-by":"crossref","first-page":"e7044","DOI":"10.1371\/journal.pone.0007044","volume":"4","author":"ME Hester","year":"2009","unstructured":"Hester ME, Song S, Miranda CJ, Eagle A, Schwartz PH, Kaspar BK . Two factor reprogramming of human neural stem cells into pluripotency. PLoS One 2009; 4: e7044.","journal-title":"PLoS One"},{"key":"BFemm2013124_CR100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 2011; 8: 409\u2013412.","journal-title":"Nat Methods"}],"container-title":["Experimental & Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/emm2013124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/emm2013124","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/emm2013124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T20:42:47Z","timestamp":1672951367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/emm2013124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,15]]},"references-count":100,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11]]}},"alternative-id":["BFemm2013124"],"URL":"https:\/\/doi.org\/10.1038\/emm.2013.124","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,15]]},"assertion":[{"value":"21 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}